(CNH) CNH Industrial - Ratings and Ratios
Tractors, Combines, Excavators, Loaders, Financing
Dividends
| Dividend Yield | 2.63% |
| Yield on Cost 5y | 2.92% |
| Yield CAGR 5y | 27.12% |
| Payout Consistency | 85.5% |
| Payout Ratio | 51.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 32.6% |
| Value at Risk 5%th | 52.0% |
| Relative Tail Risk | -2.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.64 |
| Alpha | -38.55 |
| CAGR/Max DD | -0.32 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.410 |
| Beta | 1.068 |
| Beta Downside | 1.169 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.70% |
| Mean DD | 27.00% |
| Median DD | 29.02% |
Description: CNH CNH Industrial October 30, 2025
CNH Industrial N.V. (NYSE:CNH) designs, manufactures, markets, sells, and finances agricultural and construction equipment worldwide through three operating segments: Agriculture, Construction, and Financial Services. The Agriculture segment offers a full range of farm machinery-including tractors, combines, harvesters, and precision-ag solutions-under the Case IH, New Holland, STEYR, and Raven brands. The Construction segment supplies excavators, dozers, loaders, and related equipment under CASE Construction, New Holland Construction, and Eurocomach. The Financial Services segment, operating as Banco CNH, provides dealer and end-customer financing, revolving credit, and trade-receivables factoring.
Key recent data points: (1) FY 2023 revenue reached approximately $28 billion, with the Agriculture segment contributing about 55 % of total sales; (2) the company reported an adjusted EBIT margin of ~9 %, reflecting pressure from higher commodity prices and supply-chain constraints; (3) CNH is accelerating its electrification roadmap, targeting a 20 % share of electric or hybrid power-train units in new sales by 2027, a move driven by tightening emissions regulations in Europe and North America. Macro-level, demand for farm equipment remains closely tied to global grain and biofuel output, while construction equipment volumes are sensitive to infrastructure spending cycles and interest-rate environments.
For a deeper quantitative view of CNH’s valuation metrics and peer comparison, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (597.0m TTM) > 0 and > 6% of Revenue (6% = 1.07b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 4.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 156.3% (prev 132.2%; Δ 24.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 3.29b > Net Income 597.0m (YES >=105%, WARN >=100%) |
| Net Debt (24.46b) to EBITDA (2.83b) ratio: 8.63 <= 3.0 (WARN <= 3.5) |
| Current Ratio 8.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.25b) change vs 12m ago -0.08% (target <= -2.0% for YES) |
| Gross Margin 28.66% (prev 32.27%; Δ -3.61pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.82% (prev 49.40%; Δ -8.58pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.49 (EBITDA TTM 2.83b / Interest Expense TTM 1.52b) >= 6 (WARN >= 3) |
Altman Z'' 5.59
| (A) 0.64 = (Total Current Assets 31.77b - Total Current Liabilities 3.92b) / Total Assets 43.26b |
| (B) 0.24 = Retained Earnings (Balance) 10.42b / Total Assets 43.26b |
| (C) 0.05 = EBIT TTM 2.27b / Avg Total Assets 43.65b |
| (D) 0.22 = Book Value of Equity 7.74b / Total Liabilities 35.42b |
| Total Rating: 5.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 45.62
| 1. Piotroski 2.50pt |
| 2. FCF Yield 6.77% |
| 3. FCF Margin 13.92% |
| 4. Debt/Equity 3.55 |
| 5. Debt/Ebitda 8.63 |
| 6. ROIC - WACC (= 2.46)% |
| 7. RoE 7.72% |
| 8. Rev. Trend -67.95% |
| 9. EPS Trend -66.75% |
What is the price of CNH shares?
Over the past week, the price has changed by +1.06%, over one month by -8.74%, over three months by -15.33% and over the past year by -21.76%.
Is CNH a buy, sell or hold?
- Strong Buy: 8
- Buy: 4
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CNH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.1 | 38.1% |
| Analysts Target Price | 13.1 | 38.1% |
| ValueRay Target Price | 9.3 | -2% |
CNH Fundamental Data Overview November 26, 2025
P/E Trailing = 20.25
P/E Forward = 16.1812
P/S = 0.6825
P/B = 1.5395
P/EG = 1.031
Beta = 1.386
Revenue TTM = 17.81b USD
EBIT TTM = 2.27b USD
EBITDA TTM = 2.83b USD
Long Term Debt = 27.13b USD (from longTermDebt, last quarter)
Short Term Debt = 86.0m USD (from shortTermDebt, last fiscal year)
Debt = 27.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 24.46b USD (from netDebt column, last quarter)
Enterprise Value = 36.62b USD (12.16b + Debt 27.41b - CCE 2.96b)
Interest Coverage Ratio = 1.49 (Ebit TTM 2.27b / Interest Expense TTM 1.52b)
FCF Yield = 6.77% (FCF TTM 2.48b / Enterprise Value 36.62b)
FCF Margin = 13.92% (FCF TTM 2.48b / Revenue TTM 17.81b)
Net Margin = 3.35% (Net Income TTM 597.0m / Revenue TTM 17.81b)
Gross Margin = 28.66% ((Revenue TTM 17.81b - Cost of Revenue TTM 12.71b) / Revenue TTM)
Gross Margin QoQ = 17.62% (prev 32.24%)
Tobins Q-Ratio = 0.85 (Enterprise Value 36.62b / Total Assets 43.26b)
Interest Expense / Debt = 1.38% (Interest Expense 378.0m / Debt 27.41b)
Taxrate = 1.47% (1.00m / 68.0m)
NOPAT = 2.23b (EBIT 2.27b * (1 - 1.47%))
Current Ratio = 8.11 (Total Current Assets 31.77b / Total Current Liabilities 3.92b)
Debt / Equity = 3.55 (Debt 27.41b / totalStockholderEquity, last quarter 7.73b)
Debt / EBITDA = 8.63 (Net Debt 24.46b / EBITDA 2.83b)
Debt / FCF = 9.86 (Net Debt 24.46b / FCF TTM 2.48b)
Total Stockholder Equity = 7.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.38% (Net Income 597.0m / Total Assets 43.26b)
RoE = 7.72% (Net Income TTM 597.0m / Total Stockholder Equity 7.73b)
RoCE = 6.50% (EBIT 2.27b / Capital Employed (Equity 7.73b + L.T.Debt 27.13b))
RoIC = 6.46% (NOPAT 2.23b / Invested Capital 34.59b)
WACC = 4.00% (E(12.16b)/V(39.57b) * Re(9.95%) + D(27.41b)/V(39.57b) * Rd(1.38%) * (1-Tc(0.01)))
Discount Rate = 9.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -3.08%
[DCF Debug] Terminal Value 64.12% ; FCFE base≈1.76b ; Y1≈1.23b ; Y5≈648.0m
Fair Price DCF = 7.48 (DCF Value 9.32b / Shares Outstanding 1.25b; 5y FCF grow -34.84% → 3.0% )
EPS Correlation: -66.75 | EPS CAGR: -26.20% | SUE: -1.73 | # QB: 0
Revenue Correlation: -67.95 | Revenue CAGR: -17.55% | SUE: 2.74 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.07 | Chg30d=-0.069 | Revisions Net=-3 | Analysts=10
EPS next Year (2026-12-31): EPS=0.59 | Chg30d=-0.209 | Revisions Net=-9 | Growth EPS=+28.2% | Growth Revenue=+2.3%
Additional Sources for CNH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle